Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors (original) (raw)
Molecular Basis for the N-Terminal Bromodomain-and-Extra-Terminal-Family Selectivity of a Dual Kinase–Bromodomain Inhibitor
Huarui Cui
Journal of Medicinal Chemistry
View PDFchevron_right
Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the Acetyl-Lysine Recognition Site of Bromodomains
Ting-Chao Chou
ACS Chemical Biology, 2013
View PDFchevron_right
4-Acyl Pyrrole Derivatives Yield Novel Vectors for Designing Inhibitors of the Acetyl-Lysine Recognition Site of BRD4(1)
Xavier Lucas, Stefan Gerhardt
View PDFchevron_right
Potent dual BET bromodomain-kinase inhibitors as value added multi-targeted chemical probes and cancer therapeutics
Ernst Schonbrunn
Molecular cancer therapeutics, 2017
View PDFchevron_right
Identification of novel natural product inhibitors of BRD4 using high throughput virtual screening and MD simulation
Jyotirmayee Padhan
View PDFchevron_right
Identification of a Novel Class of BRD4 Inhibitors by Computational Screening and Binding Simulations
Ernst Schonbrunn
ACS Omega
View PDFchevron_right
Potent and Selective Bruton’s Tyrosine Kinase Inhibitors: Discovery of GDC-0834
Scott Mitchell
Bioorganic & Medicinal Chemistry Letters, 2015
View PDFchevron_right
Rational design and development of selective BRD7 bromodomain inhibitors and their activity in prostate cancer
Sandra Alcala Ordóñez
View PDFchevron_right
Discovery of novel Bruton's tyrosine kinase (BTK) inhibitors bearing a pyrrolo[2,3-d]pyrimidine scaffold
Yang Ge
Bioorganic & medicinal chemistry, 2014
View PDFchevron_right
Structural biology contributions to tyrosine kinase drug discovery
Sandra Cowan-jacob
Current Opinion in Cell Biology, 2009
View PDFchevron_right
Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4
Bryce Allen
View PDFchevron_right
Structural variation of protein-ligand complexes of the first bromodomain of BRD4
Stephen Pickett
View PDFchevron_right
Pharmacophore based High Throughput Virtual Screening towards the Discovery of Novel BLK (B-lymphocyte kinase)tyrosine Kinase Inhibitors
SHARANAGOUD S I D R A M A P P A G O U D BIRADAR
View PDFchevron_right
Discovery of N-(3-(5-((3-acrylamido-4-(morpholine-4-carbonyl)phenyl)amino)-1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2-methylphenyl)-4-(tert-butyl)benzamide (CHMFL-BTK-01) as a highly selective irreversible Bruton's tyrosine kinase (BTK) inhibitor
Zhenquan Hu
European journal of medicinal chemistry, 2017
View PDFchevron_right
Structural insights into recognition of acetylated histone ligands by the BRPF1 bromodomain
Karen Glass
View PDFchevron_right
Structural Bioinformatics-Based Design of Selective, Irreversible Kinase Inhibitors
Chao Zhang
Science, 2005
View PDFchevron_right
Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A)
David Lugo
Bioorganic & medicinal chemistry letters, 2012
View PDFchevron_right
Discovery of potent, highly selective covalent irreversible BTK inhibitors from a fragment hit
Constantin Neagu
Bioorganic & Medicinal Chemistry Letters, 2018
View PDFchevron_right
Structural Characterization of Proline-rich Tyrosine Kinase 2 (PYK2) Reveals a Unique (DFG-out) Conformation and Enables Inhibitor Design
Matt Griffor, Leonard Buckbinder
Journal of Biological Chemistry, 2009
View PDFchevron_right
Structure-based drug design and AutoDock study of potential protein tyrosine kinase inhibitors
hamed ali
Bioinformation, 2011
View PDFchevron_right
The bromodomain: from epigenome reader to druggable target
Roberto Sanchez
Biochimica et biophysica acta, 2014
View PDFchevron_right
Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor
Jannik Andersen
Journal of Medicinal Chemistry, 2015
View PDFchevron_right
GSK6853, a Chemical Probe for Inhibition of the BRPF1 Bromodomain
Emma Jones
ACS Medicinal Chemistry Letters, 2016
View PDFchevron_right
BET Bromodomain Inhibitors With One-step Synthesis Discovered from Virtual Screen
Norbert Berndt
Journal of medicinal chemistry, 2017
View PDFchevron_right
IDENTIFICATION OF POTENT BROMODOMAIN4 (BRD4) INHIBITORS BY ENERGY-PHARMACOPHORE BASED VIRTUAL SCREENING TO TARGET BRD4-NUT MIDLINE CARCINOMA
International Journal of Pharmacy and Pharmaceutical Sciences (IJPPS)
International Journal of Pharmacy and Pharmaceutical Sciences, 2015
View PDFchevron_right
Targeting Diverse Signaling Interaction Sites Allows the Rapid Generation of Bivalent Kinase Inhibitors
Gayani Perera
ACS Chemical Biology, 2012
View PDFchevron_right
Potent and Selective N-Terminal BRD4 Bromodomain Inhibitors by Targeting Non-Conserved Residues and Structured Water Displacement
Huarui Cui
View PDFchevron_right
Searching new structural scaffolds for BRAF inhibitors. An integrative study using theoretical and experimental techniques
Ludmila Campos
Bioorganic Chemistry, 2019
View PDFchevron_right
Docking of Protein Kinase B Inhibitors: Implications in the Structure-Based Optimization of a Novel Scaffold: Docking of Protein Kinase B Inhibitors
Israel Martínez
Chemical Biology & Drug Design, 2010
View PDFchevron_right